Sargahydroquinoic acid inhibits TNFα-induced AP-1 and NF-κB signaling in HaCaT cells through PPARα activation

Biochemical and Biophysical Research Communications

Volumn 450, Issue 4, 2014, Pages 1553-1559

  Jeon, Youngsic ^a   Jung, Yujung ^a   Kim, Min Cheol ^a   Kwon, Hak Cheol ^a   Kang, Ki Sung ^b   Kim, Yong Kee ^c   Kim, Su Nam ^a  

^a Korea Institute of Science and Technology   (South Korea)

^b Gachon University College of Medicine   (South Korea)

^c Sookmyung Women's University   (South Korea)

Author keywords

AP 1; MMPs; NF B; PPAR activator; Sargahydroquinoic acid

Indexed keywords

AP-1; MMPS; NF-ΚB; PPAR ACTIVATOR; SARGAHYDROQUINOIC ACID;

ALKENES; BASE SEQUENCE; BENZOQUINONES; CELL LINE; DNA PRIMERS; HUMANS; NF-KAPPA B; PHOSPHORYLATION; PPAR ALPHA; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTOR AP-1; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84906082416     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2014.07.026     Document Type: Article

References (31)

1. V.M. Kahari, and U. Saarialho-Kere Matrix metalloproteinases in skin Exp. Dermatol. 6 1997 199 213
2. J.F. Woessner Jr. Role of matrix proteases in processing enamel proteins Connect Tissue Res. 39 1998 69 73 (discussion 141-149)
3. L. Rittie, and G.J. Fisher UV-light-induced signal cascades and skin aging Ageing Res. Rev. 1 2002 705 720
4. H. Nagase, and J.F. Woessner Jr. Matrix metalloproteinases J. Biol. Chem. 274 1999 21491 21494
5. M.D. Sternlicht, and Z. Werb How matrix metalloproteinases regulate cell behavior Annu. Rev. Cell Dev. Biol. 17 2001 463 516
6. T. Kobayashi, S. Hattori, Y. Nagai, S. Tajima, and T. Nishikawa Differential regulation of MMP-2 and MMP-9 gelatinases in cultured human keratinocytes Dermatology 197 1998 1 5
7. S. Inomata, Y. Matsunaga, S. Amano, K. Takada, K. Kobayashi, M. Tsunenaga, T. Nishiyama, Y. Kohno, and M. Fukuda Possible involvement of gelatinases in basement membrane damage and wrinkle formation in chronically ultraviolet B-exposed hairless mouse J. Invest. Dermatol. 120 2003 128 134
8. D.R. Bickers, and M. Athar Oxidative stress in the pathogenesis of skin disease J. Invest. Dermatol. 126 2006 2565 2575
9. C. Lopez-Camarillo, E.A. Ocampo, M.L. Casamichana, C. Perez-Plasencia, E. Alvarez-Sanchez, and L.A. Marchat Protein kinases and transcription factors activation in response to UV-radiation of skin: implications for carcinogenesis Int. J. Mol. Sci. 13 2012 142 172
10. A.J. Whitmarsh, and R.J. Davis Transcription factor AP-1 regulation by mitogen-Activated protein kinase signal transduction pathways J. Mol. Med. (Berl.) 74 1996 589 607
11. A. Oeckinghaus, M.S. Hayden, and S. Ghosh Crosstalk in NF-kappaB signaling pathways Nat. Immunol. 12 2011 695 708
12. K. Bender, M. Gottlicher, S. Whiteside, H.J. Rahmsdorf, and P. Herrlich Sequential DNA damage-independent and -dependent activation of NF-kappaB by UV EMBO J. 17 1998 5170 5181
13. P. Ferre The biology of peroxisome proliferator-Activated receptors: relationship with lipid metabolism and insulin sensitivity Diabetes 53 Suppl 1 2004 S43 50
14. P. Gervois, J.C. Fruchart, and B. Staels Inflammation, dyslipidaemia, diabetes and PPars: pharmacological interest of dual PPARalpha and PPARgamma agonists Int. J. Clin. Pract. Suppl. 2004 22 29
15. L. Michalik, and W. Wahli Peroxisome proliferator-Activated receptors (PPARs) in skin health, repair and disease Biochim. Biophys. Acta 1771 2007 991 998
16. T. Varga, Z. Czimmerer, and L. Nagy PPARs are a unique set of fatty acid regulated transcription factors controlling both lipid metabolism and inflammation Biochim. Biophys. Acta 2011 1812 1007 1022
17. P. Delerive, K. De Bosscher, S. Besnard, W. Vanden Berghe, J.M. Peters, F.J. Gonzalez, J.C. Fruchart, A. Tedgui, G. Haegeman, and B. Staels Peroxisome proliferator-Activated receptor alpha negatively regulates the vascular inflammatory gene response by negative cross-talk with transcription factors NF-kappaB and AP-1 J. Biol. Chem. 274 1999 32048 32054
18. S. Ramanan, M. Kooshki, W. Zhao, F.C. Hsu, and M.E. Robbins PPARalpha ligands inhibit radiation-induced microglial inflammatory responses by negatively regulating NF-kappaB and AP-1 pathways Free Radic. Biol. Med. 45 2008 1695 1704
19. F. Chen, M. Wang, J.P. O'Connor, M. He, T. Tripathi, and L.E. Harrison Phosphorylation of PPARgamma via active ERK1/2 leads to its physical association with p65 and inhibition of NF-kappabeta J. Cell. Biochem. 90 2003 732 744
20. J.K. Kim, S. Mun, M.S. Kim, M.B. Kim, B.K. Sa, and J.K. Hwang 5,7-Dimethoxyflavone, an activator of PPARalpha/gamma, inhibits UVB-induced MMP expression in human skin fibroblast cells Exp. Dermatol. 21 2012 211 216
21. S.N. Kim, H.Y. Choi, W. Lee, G.M. Park, W.S. Shin, and Y.K. Kim Sargaquinoic acid and sargahydroquinoic acid from Sargassum yezoense stimulate adipocyte differentiation through PPARalpha/gamma activation in 3T3-L1 cells FEBS Lett. 582 2008 3465 3472
22. S.N. Kim, W. Lee, G.U. Bae, and Y.K. Kim Anti-diabetic and hypolipidemic effects of Sargassum yezoense in db/db mice Biochem. Biophys. Res. Commun. 424 2012 675 680
23. P. Boukamp, R.T. Petrussevska, D. Breitkreutz, J. Hornung, A. Markham, and N.E. Fusenig Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line J. Cell Biol. 106 1988 761 771
24. S.L. Cai, A.R. Tee, J.D. Short, J.M. Bergeron, J. Kim, J. Shen, R. Guo, C.L. Johnson, K. Kiguchi, and C.L. Walker Activity of TSC2 is inhibited by AKT-mediated phosphorylation and membrane partitioning J. Cell Biol. 173 2006 279 289
25. A.M. Mayer, A.D. Rodriguez, R.G. Berlinck, and N. Fusetani Marine pharmacology in 2007-8: Marine compounds with antibacterial, anticoagulant, antifungal, anti-inflammatory, antimalarial, antiprotozoal, antituberculosis, and antiviral activities; affecting the immune and nervous system, and other miscellaneous mechanisms of action Comp. Biochem. Physiol. C: Toxicol. Pharmacol. 153 2011 191 222
26. A.M. Mayer, A.D. Rodriguez, R.G. Berlinck, and M.T. Hamann Marine pharmacology in 2005-6: Marine compounds with anthelmintic, antibacterial, anticoagulant, antifungal, anti-inflammatory, antimalarial, antiprotozoal, antituberculosis, and antiviral activities; affecting the cardiovascular, immune and nervous systems, and other miscellaneous mechanisms of action Biochim. Biophys. Acta 1790 2009 283 308
27. A.M. Mayer, A.D. Rodriguez, R.G. Berlinck, and M.T. Hamann Marine pharmacology in 2003-4: marine compounds with anthelmintic antibacterial, anticoagulant, antifungal, anti-inflammatory, antimalarial, antiplatelet, antiprotozoal, antituberculosis, and antiviral activities; affecting the cardiovascular, immune and nervous systems, and other miscellaneous mechanisms of action Comp. Biochem. Physiol. C: Toxicol. Pharmacol. 145 2007 553 581
28. G.J. Fisher, S.C. Datta, H.S. Talwar, Z.Q. Wang, J. Varani, S. Kang, and J.J. Voorhees Molecular basis of sun-induced premature skin ageing and retinoid antagonism Nature 379 1996 335 339
29. P.S. Friedmann, H.L. Cooper, and E. Healy Peroxisome proliferator- Activated receptors and their relevance to dermatology Acta Derm. Venereol. 85 2005 194 202
30. P. Delerive, J.C. Fruchart, and B. Staels Peroxisome proliferator- Activated receptors in inflammation control J. Endocrinol. 169 2001 453 459
31. P. Delerive, P. Gervois, J.C. Fruchart, and B. Staels Induction of IkappaBalpha expression as a mechanism contributing to the anti-inflammatory activities of peroxisome proliferator-Activated receptor-Alpha activators J. Biol. Chem. 275 2000 36703 36707